Target intelligence / Profile preview

Vitamins (null)

Target
null
Molecular classification
Other (Vitamins are organic compounds, but not a single molecular class), Not a receptor, enzyme, transporter, or single molecular entity
01

Overview

Vitamins are a chemically diverse class of essential organic compounds required in small amounts for normal metabolism, growth, and physiological functioning in humans[1][4][5][7]. They are categorized as either fat-soluble (A, D, E, K) or water-soluble (B-complex, C)[1][5][7]. Each vitamin has distinct biological roles, such as serving as enzyme cofactors, antioxidants, or regulators of cellular processes[1][3][6]. Deficiency in specific vitamins can result in characteristic diseases, while excessive intake—mainly of fat-soluble forms—can cause toxicity[1][4]. Since “Vitamins” does not refer to a single molecular target, it is not appropriate to classify it as a canonical target for drug discovery or targeted therapy[1][5][7]. In summary, “Vitamins” as queried here is an incorrect designation for a single molecular target, receptor, or druggable entity. The term applies to a group of distinct nutrients, each of which can be discussed individually as potential drug targets or in terms of their therapeutic importance[1][5][7].

Other names
Essential vitaminsMicronutrientsFat-soluble vitamins (A, D, E, K)Water-soluble vitamins (B-complex, C)
02

Mechanism of action

null

03

Biological functions

Cofactor in metabolismRegulation of gene expression (e.g. Vitamin A, D)Antioxidant function (e.g. Vitamin C, E)Hemostasis/blood clotting (Vitamin K)Bone health (Vitamin D, K)Immune supportNervous system support (B vitamins, C)
04

Disease associations

Disease prevention (deficiency leads to a variety of deficiency diseases)Metabolic disordersHormonal dysregulation (Vitamin D)Neurodegeneration (Vitamin E, B-complex)Anemia (B12, folate)Other (role in many disease processes due to deficiency or, rarely, excess)
05

Safety considerations

Hypervitaminosis (toxicity, especially for fat-soluble vitamins A, D, E, K)Deficiency-related diseases (e.g., scurvy for Vitamin C, rickets for Vitamin D, night blindness for Vitamin A, beriberi for B1)Drug-vitamin interactions (e.g., anticoagulants with vitamin K)
06

Biomarkers

Serum vitamin levels (e.g. 25-hydroxy vitamin D, serum B12)Functional status markers (homocysteine for B12/folate, prothrombin time for Vitamin K)Clinical deficiency/excess symptoms

Beyond the preview

Go deeper on Vitamins (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vitamins (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call